ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Clinical trials for ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION explained in plain language.
Never miss a new study
Get alerted when new ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION trials appear
Sign up with your email to follow new studies for ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot aims to boost immunity against HPV in HIV patients
Disease control Not yet recruitingThis study tests an immunotherapy called PDS0101 in 27 adults with both HIV and HPV 16. The goal is to see if it is safe and can strengthen the immune system's response against HPV, which can cause cancers like anal and cervical cancer. All participants will receive three doses o…
Matched conditions: ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
HPV vaccine may stop precancerous lesions from returning
Prevention Not yet recruitingThis study tests whether the HPV vaccine can prevent the return of high-grade squamous intraepithelial lesions (HSIL) in people who have already been treated for them. About 984 adults aged 18–55 with HPV-related HSIL of the cervix, vulva, vagina, penis, or anus will receive eith…
Matched conditions: ANAL HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC